Investigating the relationship between Severity of Illness and the modified Rankin Scale in ischemic stroke patients with response mapping

Objectives: To investigate the resources used by ischemic stroke patients when hospitalized, and examine this relationship by stroke severity. Comparing a bottom-up costing approach with national top-down costs.

Analysis of in-hospital resource use after an ischemic stroke

Objectives: To investigate the resources used by ischemic stroke patients when hospitalized, and examine this relationship by stroke severity. Comparing a bottom-up costing approach with national top-down costs.

Quality of life of patients experiencing cancer-associated thrombosis

Objectives: Cancer patients are at high risk of venous thromboembolism (VTE), provoked by the cancer, chemotherapies or co-morbidities. The CATCH trial investigated the benefits of extended treatment with tinzaparin (LMWH) versus warfarin for the prevention of recurrent VTE events in cancer patients experiencing a VTE.

Health state utilities in non-small cell lung cancer: An international study

Aim: Quality of life weights (utilities) are an important input in economic evaluation and evidence suggests that there can be important differences between countries.

Place of residence and employment status after stroke

Objectives: To investigate the living and employment situation of patients after stroke, and examine whether this differs by degree of disability. Methods: We conducted an observational retrospective study among 569 post-stroke patients and examined changes in employment and living situation.

Quality of Life Decrements after Stroke

Objectives: To quantify which factors affect the quality of life valuations (QoL) of patients after stroke. Methods: 569 ischemic stroke patients were recruited into a retrospective, observational study in 10 teaching and regional hospitals across Belgium.

Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin’s lymphoma in England and Wales

Objective: To evaluate the cost-effectiveness of bendamustine-rituximab (B-R) compared with CHOP-R and CVP-R as first-line treatment for patients with advanced indolent non-Hodgkin’s lymphoma (NHL).

Investigating Incoherence Gives Insight: the case of anti-platelet therapy for stroke prevention

Objective: To identify confounding factors that may explain the incoherence between direct and indirect evidence in a published analysis comparing extended-release dipyridamole (ERDP) plus aspirin to clopidogrel for the reduction of stroke.

Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment

Background: Patients with ulcerative colitis (UC) frequently require long-term therapy to prevent relapse. Treatments such as 5-aminosalicylic acid (5-ASA [mesalazine]) are efficacious and well tolerated, but adherence to treatment is often poor.

Cost of hospitalization for cerebrovascular disorders in Belgium

Background: There is only scarce information on the incidence and costs of stroke in Belgium. Knowledge of these figures permits targeted allocation of resources and aids cost efficacy estimates.